CompanyGraph
Zylox-Tonbridge Medical Technology Co., Ltd.
2190 · HKEX · China
Price data from its 818 listing on FSX, quoted in EUR
zyloxtb.comFinancials as of FY2024–FY2025
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleLevered free cash flow is $18.97M, above the global median of $16.24M
- FinancialsLow earnings quality
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.29%
Annual Rate
HKD 0.25Paid annual
Payout Ratio
13.3%Sustainable
Payback Period
8.8 yr
Last Ex-Dividend
May 27, 2026
The reported statements, read against the company's own industry.
The statements on file don't all cover the same year: income statement FY2025, balance sheet FY2024, cash-flow statement FY2024. Each figure below is labelled with the year it comes from.
Financials view
Market Capitalization
8.24BHKD1.05B · vs all stocks (USD)
Trailing P/E
22.97xvs Medical Devices peers
Revenue (TTM)
1.22BHKD155.94M · vs all stocks (USD)
Profit Margin
23.11%vs Medical Devices peers
Beta
0.2800xvs all stocks
52-Week Change
-8.52%vs all stocks
Market Capitalization
8.24BHKD1.05B · vs all stocks (USD)
Enterprise Value
5.87BHKD747.75M · vs all stocks (USD)
Trailing P/E
22.97xvs Medical Devices peers
Forward P/E
12.84xvs Medical Devices peers
Price to Sales (TTM)
6.26xvs Medical Devices peers
Price to Book (MRQ)
1.81xvs Medical Devices peers
Enterprise to Revenue
4.79xvs Medical Devices peers
Enterprise to EBITDA
21.86xvs Medical Devices peers
Profit Margin
23.11%vs Medical Devices peers
Operating Margin
21.66%vs Medical Devices peers
Return on Assets (TTM)
3.54%vs Medical Devices peers
Return on Equity (TTM)
7.72%vs Medical Devices peers
Revenue (TTM)
1.22BHKD155.94M · vs all stocks (USD)
Revenue per Share (TTM)
3.31HKDUpdated Jul 17, 2026Quarterly Revenue Growth
38.20%vs Medical Devices peers
Gross Profit (TTM)
882.64MHKD112.50M · vs all stocks (USD)
EBITDA (TTM)
268.31MHKD34.20M · vs all stocks (USD)
Net Income (TTM)
282.72MHKD36.04M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
292.40%vs Medical Devices peers
Operating Cash Flow (TTM)
445.26MHKD56.75M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
148.85MHKD18.97M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.2516HKDUpdated Jul 17, 2026Trailing Annual Dividend Yield
1.29%vs all stocks
Payout Ratio
13.26%vs Medical Devices peers
EPS (Basic)
0.7646CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.7552CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
319.61MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
319.61MSharesFY2025 · Dec 31, 2025Operating Cash Flow
19.54MCNYFY2024 · Dec 31, 2024Free Cash Flow
-171.73MCNYFY2024 · Dec 31, 2024Cash & Cash Equivalents (End of Period)
418.11MCNYFY2024 · Dec 31, 2024Starting Profit (CF Statement)
100.26MCNYFY2024 · Dec 31, 2024Stock-based Compensation
23.74MCNYFY2024 · Dec 31, 2024Other Non-cash Items
-65.17MCNYFY2024 · Dec 31, 2024Change in Accounts Receivable (CF)
-351.00KCNYFY2024 · Dec 31, 2024Change in Other Assets/Liabilities
-38.93MCNYFY2024 · Dec 31, 2024Capital Expenditures
-191.26MCNYFY2024 · Dec 31, 2024Net Acquisitions
-1.10MCNYFY2024 · Dec 31, 2024Purchase of Investments
-1.39BCNYFY2024 · Dec 31, 2024Sale of Investments
772.02MCNYFY2024 · Dec 31, 2024Other Investing Activity
7.21MCNYFY2024 · Dec 31, 2024Net Investing Cash Flow
-801.86MCNYFY2024 · Dec 31, 2024Long-term Debt Payments
-50.00MCNYFY2024 · Dec 31, 2024Net Short-term Debt Issuance
87.00MCNYFY2024 · Dec 31, 2024Common Stock Repurchase
-66.91MCNYFY2024 · Dec 31, 2024Other Financing Charges
-5.37MCNYFY2024 · Dec 31, 2024Net Financing Cash Flow
-35.22MCNYFY2024 · Dec 31, 2024Shares Outstanding
317.74MSharesUpdated Jul 17, 2026Float Shares
165.58MSharesUpdated Jul 17, 2026% Held by Insiders
48.21%vs all stocks
% Held by Institutions
31.91%vs all stocks
Total Cash (MRQ)
2.00BHKD255.38M · vs all stocks (USD)
Total Cash per Share (MRQ)
5.13HKDUpdated Jul 17, 2026Total Debt (MRQ)
73.63MHKD9.38M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0197xvs Medical Devices peers
Current Ratio (MRQ)
5.98xvs Medical Devices peers
Book Value per Share (MRQ)
11.07HKDUpdated Jul 17, 2026Total Assets
3.45BCNY511.77M · vs all stocks (USD)
Total Current Assets
1.53BCNYFY2024 · Dec 31, 2024Total Liabilities
351.56MCNYFY2024 · Dec 31, 2024Total Non-current Assets
1.92BCNYFY2024 · Dec 31, 2024Total Non-current Liabilities
17.39MCNYFY2024 · Dec 31, 2024Total Current Liabilities
334.17MCNYFY2024 · Dec 31, 2024Cash
2.34BCNYFY2024 · Dec 31, 2024Cash Equivalents
-1.93BCNYFY2024 · Dec 31, 2024Cash & Cash Equivalents
418.11MCNYFY2024 · Dec 31, 2024Other Short-term Investments
864.78MCNYFY2024 · Dec 31, 2024Accounts Receivable
1.54MCNYFY2024 · Dec 31, 2024Inventory
205.48MCNYFY2024 · Dec 31, 2024Accounts Payable
69.37MCNYFY2024 · Dec 31, 2024Short-term Debt
89.40MCNYFY2024 · Dec 31, 2024Other Current Liabilities
2.66MCNYFY2024 · Dec 31, 2024Long-term Debt
1.50MCNYFY2024 · Dec 31, 2024Common Stock (Book)
330.18MCNYFY2024 · Dec 31, 2024Retained Earnings
65.28MCNYFY2024 · Dec 31, 2024Total Shareholders' Equity
3.10BCNY459.66M · vs all stocks (USD)
Treasury Stock
100.70MCNYFY2024 · Dec 31, 202452-Week Low
17.10HKDUpdated Jul 17, 202652-Week High
28.00HKDUpdated Jul 17, 202652-Week Change
-8.52%vs all stocks
Beta
0.2800xvs all stocks
50-Day MA
20.10HKDUpdated Jul 17, 2026200-Day MA
22.82HKDUpdated Jul 17, 2026Avg 10-Day Volume
380.65KSharesUpdated Jul 17, 2026Avg 30-Day Volume
505.29KSharesUpdated Jul 17, 2026Diluted EPS (TTM)
0.8700HKDUpdated Jul 17, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.61
Altman Z-Score 12.82: safe zoneNotable
Altman Z-Score: 12.82
High structural barrier to entryNotable
Barrier to Entry: 2.44
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Levered free cash flow is $18.97M, above the global median of $16.24MNotable
Levered free cash flow (USD): 18,972,535.714Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Shanghai Haohai Biological Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Medincell SA
Tier 1ProductionApproval-Gated PipelineRule
Cronos Group Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jiangsu Yahong Meditech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Xiangyu Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Lexicon Pharmaceuticals, Inc.
Tier 1ProductionApproval-Gated PipelineRule
China Animal Husbandry Industry Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Alto Neuroscience Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Suzhou Highfine Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Blue Jet Healthcare Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow